Aurinvest

PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.

PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.

OpenDataSoft provides a comprehensive data-sharing platform that enables organizations to publish, manage, visualize, and share their data effectively. The company's software-as-a-service (SaaS) solution serves as a centralized hub, allowing users to access and analyze data in various formats. By facilitating data publishing and application programming interface management, OpenDataSoft empowers teams to create engaging digital experiences and fosters collaboration through data reuse. The platform aims to accelerate digital transformation, enhance operational efficiency, and help organizations derive value from their data by promoting a culture of sharing and accessibility.

PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.

OpenDataSoft provides a comprehensive data-sharing platform that enables organizations to publish, manage, visualize, and share their data effectively. The company's software-as-a-service (SaaS) solution serves as a centralized hub, allowing users to access and analyze data in various formats. By facilitating data publishing and application programming interface management, OpenDataSoft empowers teams to create engaging digital experiences and fosters collaboration through data reuse. The platform aims to accelerate digital transformation, enhance operational efficiency, and help organizations derive value from their data by promoting a culture of sharing and accessibility.

PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.